Acrylamide (ACR) is a conjugated Type-2 alkene that produces synaptic toxicity presumably by sulfhydryl adduction. The , -unsaturated carbonyl of ACR is a soft electrophile and, therefore, adduction of nucleophilic thiol groups could occur through a conjugate (Michael) addition reaction. To address the mechanism of thiol adduct formation and corresponding neurotoxicological importance, we defined structure-toxicity relationships among a series of conjugated Type-2 alkenes (1µM-10mM), which included acrolein and methylvinyl ketone. Results show that exposure of rat striatal synaptosomes to these chemicals produced parallel, concentration-dependent neurotoxic effects that were correlated to loss of free sulfhydryl groups. Although differences in relative potency were evident, all conjugated analogs tested were equiefficacious with respect to maximal neurotoxicity achieved. In contrast, non-conjugated alkene or aldehyde congeners did not cause synaptosomal dysfunction or sulfhydryl loss. Acrolein and other , -unsaturated carbonyls are bifunctional (electrophilic reactivity at the C-1 and C-3 positions) and could produce in vitro neurotoxicity by forming protein cross-links rather than thiol monoadducts. Immunoblot analysis detected slower migrating, presumably derivatized, synaptosomal proteins only at very high acrolein concentrations (> 25mM). Exposure of synaptosomes to high concentrations of ACR (1M), N-ethylmaleimide (10mM) and methyl vinyl ketone (100mM) did not alter the gel migration of synaptosomal proteins. Furthermore, hydralazine (1 mM), which blocks the formation of protein cross-links, did not affect in vitro acrolein neurotoxicity. Thus, Type-2 conjugated alkenes produced synaptosomal toxicity that was linked to a loss of thiol content. This is consistent with our hypothesis that the mechanism of ACR neurotoxicity involves formation of Michael adducts with protein sulfhydryl groups.
INTRODUCTION

Acrylamide (ACR) is a ubiquitous neurotoxicant that is used extensively in various industrial
settings (e.g., water and wastewater management, ore processing, and dye synthesis) and in scientific laboratories for the electrophoretic separation of macromolecules. ACR is also a food contaminant formed during high-temperature preparation of certain potato-or grain-based products. Although the polymer is non-toxic, exposure to monomeric ACR can produce mental status changes, ataxia and skeletal muscle weakness in humans and experimental animal models (reviewed in LoPachin et al., 2003) . Accumulating evidence suggests that these neurological deficits are mediated by an early disruption of neurotransmission followed by nerve terminal degeneration in the PNS and CNS (reviewed in LoPachin et al., 2002 LoPachin et al., , 2003 . Although the mechanism of synaptic toxicity is unknown, results from recent molecular and proteomic determinations suggest that ACR selectively adducts thiol groups on cysteine residues of several presynaptic proteins (Barber and LoPachin, 2004; . Thiol adduction has significant neurotoxic implications since it is now recognized that the regulatory functions of certain synaptic proteins (e.g., SNAP-25, v-ATPase, N-ethylmaleimide sensitive factor) are determined by the redox states of specific sulfhydryl groups (reviewed in LoPachin and . Based on this evidence, we have hypothesized that ACR alkylation of essential thiol groups impairs the function of presynaptic proteins that regulate neurotransmission (reviewed in LoPachin et al., 2002 LoPachin et al., , 2003 .
ACR is an , -unsaturated carbonyl derivative and is, therefore, classified as a conjugated Type-2 alkene; i.e., an electrophilic group linked to an alkene carbon, which forms a conjugated structure (Kemp and Vellaccio, 1980) . Since the pi electrons in a conjugated system are highly polarizable, the , -unsaturated carbonyl of ACR is categorized as a soft electrophile. Characteristically, soft electrophiles will preferentially form adducts with soft nucleophiles, which in biological systems are primarily sulfhydryl groups on cysteine residues (Coles, 1984-85; Hinson and Roberts, 1992; LoPachin and DeCaprio, 2005; Pearson and Songstad; 1967) . Our proposed mechanism of ACR-induced nerve terminal damage is based on adduction of functionally critical protein thiol groups. However, whether such adduct formation is a principal neuropathogenic step in ACR neurotoxicity has not been determined conclusively and, in fact, previous research suggests that sulfhydryl alkylation is not mechanistically relevant (Hoshimoto and Aldridge, 1970; Lapin et al., 1982; Martenson et al., 1995) .
To define the thiol adduct chemistry of ACR and its relevance to corresponding neurotoxicological mechanisms, we determined the structure-toxicity relationships for a series of conjugated Type-2 alkenes and their non-conjugated analogs. Thus, if thiol adduction is neurotoxic and is mediated by the polarizability (softness) of the conjugated Type-2 alkene system, then other conjugated analogs should also produce thiol-based neurotoxicity. Conversely, structural analogs that are non-conjugated and are, therefore, not soft electrophiles will not form thiol adducts and should be devoid of neurotoxic activity.
Acrolein is structurally similar to ACR and is prototypical of conjugated Type-2 alkenes (Fig. 1) .
Similarly, N-ethylmaleimide (NEM) is also an , -unsaturated carbonyl derivative and is a welldocumented sulfhydryl alkylating agent. We therefore determined the effects of these conjugated alkenes and several additional structural analogs ( Fig. 1 ) on selected neurochemical parameters of striatal synaptosomes. As a quantitative index of sulfhydryl adduct formation, the free thiol content of toxicant-exposed synaptosomes was measured. Cysteine adduct formation was verified by mass spectrometric analysis of synaptosomal protein exposed in vitro to acrolein.
MATERIALS AND METHODS
Chemicals and Materials
Unless otherwise indicated all reagents were HPLC grade or better and water was doubly 
Preparation of Striatal Synaptosomes and Synaptic Vesicles
The striatum was chosen as a source for synaptosomes and synaptic vesicles based on previous research showing that ACR intoxication of rats was associated with early structural and functional damage to nerve terminals in this brain region (Lehning et al., 2003; . Rat brain striatal synaptosomes were isolated by the Percoll gradient method of . In brief, bilateral striata (100-120 mg wet wt. tissue) were rapidly removed from anesthetized (isoflurane inhalation) rats and minced in cold (4ºC) buffer containing sucrose 0.32 M, EDTA 1 mM and dithiothreitol 0.25 mM (SED gradient buffer; pH 7.4). Tissue was gently homogenized in SED buffer (10 passes in a Teflon-glass homogenizer; 700 RPM) and the resulting homogenate was centrifuged at 1,000 g (10 min, 4ºC). The pellet (P1) was washed once and supernatants (S1 and S2) were combined.
Protein content of the pooled supernatant was determined by the Bradford assay using bovine serum albumin as standard. The protein concentration of the supernatant was adjusted with SED to 5 mg/ml and then layered on top of a freshly prepared 4-step discontinuous Percoll gradient (3%, 10%, 15% and 23% Percoll in SED, pH 7.4). Gradients were centrifuged at 32,000 g for 6 mins and synaptosomes were collected at the last interface (15%/23%). Synaptosomes were washed twice in Kreb's buffer containing NaCl 140 mM, KCl 5 mM, NaHCO 3 5 mM, MgCl 2 1 mM, NaH 2 PO 4 1.2 mM, glucose 10 mM and Hepes 10 mM (pH 7.4), pelleted and then resuspended.
Striatal synaptic vesicles were prepared according to . In brief, rat striata were homogenized in ice-cold 0.32 M sucrose in a glass homogenizer using 10 strokes of a Teflon pestle. All centrifugation steps were preformed at 4º C. The homogenate was centrifuged at 800 g for 12 mins and the resulting supernatant was centrifuged at 22,000 g for 10 mins. The P2 crude synaptosomal pellet was subjected to osmotic shock (5 mins) by homogenization (5 strokes with Teflon pestle) in 2 ml of distilled water. Osmolarity was restored by addition (1 ml) of a HEPES (0.25 M)-potassium tartrate (1 M) buffer (pH 7.5). The suspension was centrifuged at 20,000 g for 20 mins and the supernatant was centrifuged at 55,000 g for 60 mins. MgSO 4 (1 mM) buffer was added to the supernatant, which was then centrifuged at 100,000 g for 50 mins. The P5 pellet, which contained the isolated synaptic vesicles (20-30 µg protein), was resuspended in vesicle assay buffer containing (in mM): HEPES (25), potassium tartrate (100), ascorbic acid (1.7) EGTA (0.5), EDTA (0.1), MgSO 4 (2) and KCl (10 mM).
In Vitro Effects of Structural Analogs on Synaptosomal and Vesicular Function
We determined the in vitro effects of , -unsaturated carbonyl derivatives on: 1) 
Kinetic Analysis of In Vitro Acrolein Neurotoxicity: Synaptosomal and Vesicular Transport
In separate studies, we determined the effects of in vitro acrolein on the kinetic parameters of DA transport in striatal synaptosomes and synaptic vesicles (for methodological details see . Briefly, synaptosomes (10 µg protein) were exposed (15 mins x 30ºC) to the corresponding IC 50 of acrolein (50 µm) or to Krebs-Hepes buffer. Acrolein-exposed and control synaptosomes were washed, filter trapped and superfused with graded 
Measurement of Free Thiols
The concentration-dependent effects of structural analogs ( 5,5'-Dithiobis(2-nitrobenzoic acid) (DTNB; 3 mM) was added and, following equilibration (5 min, 25ºC), absorbance was read at 412 nm using a Jenway 6305 spectrophotometer. A reagent blank without DTNB was used to zero the spectrophotometer. The concentration of 3-carboxylato-4-nitrothiophenolate, the thiol anion released during adduction of sulfhydryl groups by the disulfide reagent DTNB, was calculated by the molar extinction coefficient, 1.36 x 10 4 M -1 cm -1 . Sulfhydryl data were calculated as nmol/mg synaptosomal protein and the toxicant effects were expressed as mean percent of control ± SEM. The free thiol data for each toxicant were fitted by nonlinear regression analysis (r 2 for all curves > 0.90) and respective IC 50 's and 95% confidence intervals were calculated by the Cheng-Prusoff equation (Prism TM 3.0, GraphPad Software, San Diego, CA). Linear regression analysis was used to assess the relationship between analog-induced changes in synaptosomal free sulfhydryl groups and changes in the measured functional parameters (e.g., vesicular uptake).
Corresponding coefficients of determination (r 2 ) were calculated from the Pearson correlation coefficient (InStat TM 3.0, GraphPad Software, San Diego, CA).
Western Blot Analysis
Striatal synaptosomes were prepared and exposed (15 mins) to graded concentrations of ACR (10mM-1M), acrolein (0.5-100 mM), NEM (0.1-10 mM) or methyl vinyl ketone (0.5-100 mM).
Synaptosomes were washed and proteins (20 µg) were resolved by SDS-PAGE and then transferred to nitrocellulose membranes. After transfer, membranes were blocked with 5.0% dried non-fat milk in TBS (Tris-HCl 20 mM, NaCl 0.5M, pH 8.3) for 45 mins and then rinsed. Membranes were incubated for 2 hrs at 25ºC with the appropriate primary antibody diluted in 5.0% dried milk/TBS: antibodies to NSF (1:2000), SNAP-25 (1:1000), synaptobrevin (1:1000), synaptophysin (1:1000). Following primary antibody incubation, membranes were washed in TBS and incubated for 1 hr at 25ºC with an appropriate alkaline phosphatase-conjugated secondary antibody. Membranes were washed with TBS and bound secondary antibody was visualized with a ProtoBlot II AP system.
Mass Spectrometric Analysis of adducts in acrolein-exposed synaptosomes.
Synaptosomes (200 µg) were incubated with acrolein (1 mM) in Krebs buffer (pH 7.0) for 15 mins at 37° C. Following incubation, synaptosomal protein was precipitated by adding 9 volumes of acetone acidified to pH 3 with HCl. Samples were stored at -20ºC for 30 minutes to ensure complete protein precipitation followed by centrifugation at 18,000 x g for 20 minutes at 4ºC. The pellet was washed with acetone and resuspended in a buffer containing 0.1% SDS, 200mM Tris-HCl (pH 8.3), 5 mM EDTA and 6M urea. Samples were reduced with TCEP, alkylated with iodoacetamide and digested with trypsin as described previously (Schrimpf et al., 2005 identifications were accepted if they could be established at greater than 95% probability as specified by the Peptide Prophet algorithm. Protein identifications were accepted if they could be established at greater than 90% probability and contained at least one identified peptide. Protein probabilities were assigned by the Protein Prophet algorithm. Proteins that contained similar peptides and could not be differentiated based on MS/MS analysis alone were grouped to satisfy the principles of parsimony.
Acrolein adducts were identified by the addition of 56 amu to an amino acid residue. Adducts were validated by manual interpretation of the MS/MS data.
RESULTS
Effects of Acrolein, ACR or NEM on Synaptosomal Function and Free Thiol Content
The effects of ACR on synaptosomal function and thiol content have been the focus of previous studies from this laboratory . Therefore, to simplify the presentation of data, the ACR results are provided in Table 1 . Figure 2 shows the in vitro effects of acrolein and NEM on three parameters of nerve terminal function presented in blue; i.e., synaptosomal neurotransmitter release (2A), membrane neurotransmitter uptake (2B) and synaptic vesicle transport (2C). Parallel measurements of synaptosomal and vesicular free thiol contents are also presented in red.
Synaptosomal Release. Figure 2A shows that in vitro exposure of striatal synaptosomes to acrolein or NEM produced parallel concentration-dependent decreases in evoked 3 H-DA release. The loss of function induced by each toxicant corresponded to graded decreases in synaptosomal free thiol content. In vitro exposure to ACR produced a parallel concentration-dependent decrease in release that was closely correlated to a reduction in synaptosomal thiol content (Table 1 ; see also . The rank order of the respective concentration curves indicated that NEM and acrolein were significantly more potent than ACR with respect to release inhibition; i.e., the respective IC 50 's are 10µM, 811µM and 688mM (Table 1) .
Synaptosomal Transport. Exposure of striatal synaptosomes to acrolein or NEM resulted in parallel concentration-dependent reductions in membrane 3 H-DA transport (Fig. 2B) . The inhibition of transport caused by in vitro exposure to these analogs was closely correlated (r 2 = 0.91 and 0.96, respectively) to a reduction in synaptosomal free thiol content (Fig. 2B) . ACR exposure produced a parallel graded decrease in membrane transport that corresponded (r 2 = 0.96) to a graded reduction in sulfhydryl content (Table 1 ; see also Fig. 4 ). Acrolein and NEM were of comparable potency (IC 50 's = 53µM vs. 47µM, respectively) and both were significantly more potent than ACR with respect to transport inhibition (IC 50 = 438mM; Table 1 ). Kinetic analysis of the in vitro acrolein effect on synaptosomal transport revealed a statistically significant decrease in V max , with no change in K m (Table   2 ).
Vesicular Transport. In vitro incubation of synaptic vesicles with acrolein or NEM produced concentration-dependent decreases in 3 H-DA transport that were correlated (r 2 = 0.90 and 0.94, respectively) to a reduction in vesicular sulfhydryl content (Fig. 2C) . ACR incubation caused similar parallel effects on vesicular transport and thiol content ( Table 1 ). The order of potency for inhibition of vesicular transport was: NEM (6.2µM)> acrolein (213µM) >> ACR (233mM; Table 1 ). Kinetic analysis indicated that acrolein significantly decreased V max of vesicular transport and increased corresponding K m (Table 2) .
These data and results from previous research show that in vitro exposure to the , -unsaturated carbonyl derivatives, acrolein, NEM or ACR, produced parallel, concentration-dependent inhibitions of synaptosomal function. The inhibitory effects of these structural analogs were closely correlated to reductions in synaptosomal sulfhydryl content. With respect to inhibition of synaptosomal function, NEM was generally more potent than acrolein. Both toxicants, however, were substantially more potent than ACR; i.e., compare the respective IC 50 's for a given parameter (Table 1) . Finally, our kinetic analyses revealed that the nerve terminal effects of in vitro acrolein were due to a reduction in Vmax. ACR and NEM also produced similar kinetic changes , which together represent noncompetitive inhibition due to irreversible (covalent) protein-chemical interactions (reviewed in LoPachin and DeCaprio, 2005) .
Structure-Toxicity Relationships
For a comprehensive analysis of structure-toxicity relationships, we selected 3 H-DA transport as a representative synaptosomal parameter and determined the corresponding effects of several conjugated and non-conjugated structural analogs (Figs. 3A and 4A ). These functional studies were correlated with measurements of synaptosomal sulfhydryl content (Figs. 3B and 4B ). Figure 3 shows that when synaptosomes were exposed to a relatively broad concentration range (1µM-10mM) of non-conjugated analogs; i.e., alkenes (allyl chloride and allyl alcohol) or aldehydes (propanal), no changes in either neurotransmitter uptake (3A) or free thiol content (3B) were observed. With respect to allyl chloride and allyl alcohol, the lack of in vitro effects is in contrast to the documented ability of these alkenes to produce toxicity in exposed laboratory animals (e.g., see Jaeschke et al., 1987; Nagano et al., 1991) .
Since the induction of in vivo toxicity by allyl chloride or allyl alcohol requires metabolic biotransformation (He et al., 1995; Jaeschke et al., 1987) , our finding that these non-conjugated analogs did not affect in vitro synaptosomal activity is consistent with the limited capacity of neurons for xenobiotic metabolism (Minn et al., 1991) . Conjugated , -unsaturated analogs, however, produced parallel, concentration-dependent decreases in synaptosomal transport (Fig. 4A) . The decreases in neurotransmitter transport induced by each structural congener were highly correlated to corresponding reductions in sulfhydryl content (Fig. 4B) Fig. 2 ). These structure-toxicity data indicate that the synaptosomal toxicity of the , -unsaturated derivatives (ACR, acrolein, NEM, MVK, MA) is related to their common type-2 conjugated alkene structure; i.e., non-conjugated alkenes or aldehydes did not cause toxicity. These data also indicate that loss of synaptosomal free thiols is importantly involved in the inhibition of neurotransmitter uptake induced by these analogs.
Cross-Link Formation by Acrolein and Structural Congeners
Acrolein and other , -unsaturated carbonyls are bifunctional electrophiles and, therefore, initial adduct formation at the -carbon atom might be followed by attack from a neighboring nucleophile at the reactive carbonyl carbon atom resulting in the formation of protein crosslinks (Esterbauer et al., 1991; Kurtz and Lloyd, 2003) . To identify crosslinks that might form during our study of synaptosomal function, the presence of higher molecular weight derivatized proteins was detected by electrophoretic separation and immunoblot analysis. This approach has been used in previous studies of the neurofilament crosslinks formed during 2,5-hexanedione intoxication (e.g., see .
Results show that exposure of synaptosomes to lower concentrations of acrolein (0.5-10mM) did not affect the migration of four nerve terminal proteins (Figs. 5 and 6): SNAP-25 (5A), synaptophysin (5B), VAMP (6A, synaptobrevin) or NSF (6B). However, altered migration patterns were evident for all four proteins in synaptosomes exposed to a higher acrolein concentration (100 mM; Figs. 5 and 6). Slower migrating, presumably higher molecular weight, derivatives of native SNAP-25 and synaptophysin were evident at acrolein concentrations >25 mM. The migration of VAMP and NSF was completely truncated in synaptosomes exposed to these higher acrolein concentrations (Fig. 6) . In contrast to acrolein, high concentrations of NEM (10mM), ACR (1M) or MVK (100mM) did not affect protein migration (Fig. 7) . Hydralazine is a "protein adduct-trapping" drug that has been shown to offer some protection against the production of in vitro hepatocyte toxicity by acrolein (Kaminskas et al., 2004) . Therefore, in the present studies, we also determined the ability of hydralazine to prevent protein crosslinks and acrolein synaptosomal toxicity. Hydralazine (1mM) alone did not alter synaptosomal protein migration (Figs. 5 and 6) or thiol content (data not shown), whereas it did reduce control 3 H-DA transport by 40% (data not shown). Our research indicates that hydralazine did not abolish in vitro acrolein neurotoxicity; i.e., hydralazine (1mM) did not prevent the formation of higher molecular weight protein derivatives (Figs. 5 and 6) and it potentiated, rather than reduced, the inhibitory effect of acrolein on synaptosomal membrane transport (Fig. 8) .
Mass Spectrometric detection of adducts in acrolein-exposed synaptosomes
Two-dimensional chromatographic separation of synaptosomal peptides resulted in positive identification of 207 proteins. The majority of acrolein adducts were on cysteine residues of proteins such as Na/K-ATPase alpha 3; malate dehydrogenase 2 (Fig. 9 ), 14-3-3 protein, glyceraldehyde-3-phosphate dehydrogenase, citrate synthase, fructose bisphosphate aldolase, guanine nucleotide binding protein -subunit, succinyl coA ligase and tubulin 4. Acrolein adducts of lysine or histidine were also identified on several proteins. These MS data, in conjunction with our previous analysis of ACR adduct formation (Barber et al., 2004) , demonstrate that conjugated Type-2 alkenes can form thiol adducts and that this accounts for the loss of free sulfhydryl groups detected in the respective DTNB assays (e.g., see Fig. 4B ).
DISCUSSION
Results of the present structure-toxicity analyses indicate that exposure of striatal synaptosomes to ACR or its conjugated analogs produced parallel concentration-dependent decreases in several neurochemical parameters. For each active congener, the neurotoxic effect was highly correlated to graded decreases in synaptosomal free thiol content. In contrast, non-conjugated analogs did not cause changes in either synaptosomal function or sulfhydryl groups. This lack of neurotoxic effect is consistent with previous studies of propionamide (CH 3 CH 2 CONH 2 ), a non-conjugated ACR analog that did not affect synaptosomal function or thiol content . Together, these data indicate that the , -unsaturated carbonyl structure of ACR and other Type-2 alkenes is responsible for the corresponding in vitro neurotoxicity. The pi electrons of this conjugated structure are mobile and, as a consequence, the Type-2 alkene is a soft (polarizable) electrophile that will form adducts with soft (polarizable) nucleophiles via the Michael addition reaction (Friedman, 1973; Kemp and Vellaccio, 1980) . In biological systems, sulfhydryl groups are the preferential soft nucleophilic targets of ACR and other conjugated alkenes (Calleman, 1996; Coles, 1984-85; Esterbauer et al., 1991; Friedman, 1973; Hinson and Roberts, 1992; LoPachin and DeCaprio, 2005; Witz, 1989) . This is substantiated by our present findings that ACR, acrolein and other conjugated Type-2 analogs reduced the free sulfhydryl content of exposed synaptosomes (see also . In addition, mass spectrometric analyses have shown that ACR (Barber and LoPachin, 2004; Bordini et al., 2000; Hall et al., 1993) and acrolein (present study) can alkylate protein thiol groups. In non-conjugated alkene (e.g., allyl alcohol) or aldehyde systems (i.e., propanal), the pi electrons are not part of a resonance system and are, instead, restricted to the alkene or carbonyl functions, respectively. The carbonyl carbon of the aldehyde is a relatively hard electrophile, whereas alkenes are not electrophilic and neither group is, therefore, likely to function as a Michael acceptor for thiol adduction. Predictably, the non-conjugated compounds used in this study did not alter synaptosomal free thiol content or 3 H-DA transport (Fig. 3) .
In contrast to thiol selectivity, some previous research has emphasized the formation of lysine adducts (e.g., FDP-lysine, bis-Michael adducts) by acrolein and other , -unsaturated carbonyls (Uchida et al., 1999; Kaminskas et al., 2005) . The initial step of these reactions involves nucleophilic addition of the lysine amino group at the double bond (C-). However, acrolein is a soft electrophile whereas the -amino group of the lysine residue is a relatively hard nucleophile and, although a Michael addition between a soft electrophile and a hard nucleophile can occur, it is not a favored reaction (Coles, 1984-85; Hinson and Roberts, 1992) . This is consistent with our current mass spectrometric findings that, although acrolein formed lysine adducts, they were not prevalent. Because , -unsaturated carbonyls are bifunctional (i.e., electrophilic reactivity at the -carbon and carbonyl carbon atoms), acrolein and other chemicals in this class could disrupt synaptosomal activity by crosslinking proteins rather than by forming thiol monoadducts (Esterbauer et al., 1991, Kurtz and Lloyd, 2003) . However, our immunoblot analyses (Figs. 5-7) and studies with pharmacological crosslink blockers (Fig. 8 ) do not support a mechanistic role for protein crosslinks in the production of alkene synaptosomal toxicity.
Results of this study show that the conjugated Type-2 toxicants differed significantly in relative potency. This difference is likely ascribed to variations in the degree of relative "softness" among the conjugated carbonyl compounds used. Specifically, the "hard and soft, acids and bases" (HSAB; Pearson and Songstad, 1967) theory suggests that soft-soft interactions can be described by frontier orbital interactions. Thus, with respect to thiol adduct formation, electrons from the Highest Occupied Molecular Orbital (HOMO) of the sulfhydryl group (donor) will interact with the Lowest Unoccupied Molecular Orbital (LUMO) of, for example, the -alkene carbon of ACR (acceptor). The ease (rate of reaction) of adduct formation is determined by the extent to which the respective frontier orbitals correspond energetically; i.e., HOMO energy of the thiol group vs. LUMO energy of the , -unsaturated carbonyl. Based on the HSAB theory, the observed rank order of in vitro potencies among the Type-2 alkenes (see Fig. 4 ) should be related to the respective LUMO energies or degree of relative softness. Indeed, in preliminary studies (Gavin et al., unpublished), we have used a commercially available program for quantum chemical calculations (Spartan; Wavefunction Inc.) to calculate the respective LUMO energies of the alkenes and their non-conjugated analogs. Our initial results (Table 3) indicate that the LUMO energies for this chemical series are directly related to corresponding abilities to deplete synaptosomal thiols and impair function. Thus, defining LUMO-toxicity relationships could provide a mechanistic explanation, at the atomic level, for the relative in vitro differences in Type-2 alkene neurotoxic potencies. (TABLE 3 HERE Although the degree of polarizability (softness) might be the chemical basis for the low electrophilic reactivity of ACR, the relatively high (mM) concentrations needed in this study to produce in vitro neurotoxicity are in contrast to the predicted µM tissue concentrations achieved during in vivo intoxication (e.g., see Martenson et al., 1995) . However, in accordance with the mass action kinetics of chemicals with lower reactivity, higher ACR (or methyl acrylate) concentrations (mM) are required during acute (15 min) in vitro exposures to drive adduct formation and initiate synaptosomal toxicity.
That the adducts formed in vitro have neurotoxicological relevance is indicated by our mass spectrometric analyses which showed that the thiol adduct content of ACR-exposed synaptosomes was highly correlated (r 2 =0.99) to the induction of neurotoxicity (Barber et al., 2004; .
The higher concentrations of ACR and MA used in vitro are, therefore, in accordance with their relatively low electrophilic reactivities. The lower adduct potency of ACR is also consistent with the cumulative neurotoxicity produced by in vivo intoxication; i.e., the progression of neurological deficits in rats requires daily exposure to relatively high dose-rates (e.g., 10-50 mg/kg) for extended durations (e.g., 90-11 days; . Proteomic analyses have indicated that the formation of protein thiol adducts in nerve terminals is also cumulative and highly correlated to the onset and development of neurotoxicity in ACR-intoxicated rats (Barber and LoPachin, 2004; . These data indicate that, although adduct potency is relatively low, cumulative adduction of sulfhydryl groups is an important neuropathogenic component of ACR neurotoxicity. Thus, the characteristic in vitro and in vivo toxicodynamics of ACR are clearly related to lower electrophilic reactivity (see more detailed discussion in LoPachin and DeCaprio, 2005) .
It is not known how thiol adduct formation mediates synaptosomal dysfunction. One possibility is that , -unsaturated carbonyl derivatives deplete glutathione (GSH) and other non-protein reducing equivalents and thereby promote secondary oxidative stress (e.g., Dixit et al., 1984; Luo and Shi, 2005; Pocernich et al., 2001; Shivakumar and Ravindranath, 1992) . Whereas this could be a contributing factor, other evidence indicates that the toxicity of ACR and Type-2 congeners is more complex and that the formation of protein adducts is critically involved (e.g., Barber and LoPachin, 2004; Beiswanger et al., 1993; Biswal et al., 2003; Kaminskas et al., 2004; Ku and Billings, 1986; Park et al., 2002; Patel and Block, 1993; reviewed in Kehrer and Biswal, 2000; Reed, 1990) . That chemical alkylation of protein thiol groups is likely to have significant functional consequences is suggested by increasing evidence that the redox states of specific cysteine sulfhydryl groups regulate the activities of many rate-limiting nerve terminal proteins (e.g., Cys 264 of NSF). Therefore, adduction of these essential thiols is likely to inhibit the activities of proteins that regulate important synaptic processes (reviewed in LoPachin and DeCaprio, 2005; .
Our previous research has indicated that in vivo or in vitro exposure to ACR inhibits nerve terminal function and that this effect is mediated by formation of protein thiol adducts as revealed by mass spectrometric analyses and measurements of free sulfhydryl content (Barber and LoPachin, 2004; . These data support our original hypothesis that ACR alkylation of essential thiol groups impairs the function of proteins that regulate the synaptic vesicle cycle and other presynaptic processes (LoPachin et al., 2002 . The current results also support our hypothesis and provide additional mechanistic information that has led to a better understanding of ACR adduct chemistry and resulting neurotoxicity. Specifically, we have shown that a series of structural analogs can produce synaptosomal dysfunction and thiol loss that parallel the effects of in vitro ACR exposure.
These data emphasize the pathophysiological relevance of sulfhydryl adduction and show clearly that such adduct formation is a product of the conjugated Type-2 system of ACR and other , -unsaturated carbonyl derivatives. In a broader sense, our in vitro findings suggest that conjugated alkenes, as a chemical class, could produce neurotoxicity via a common molecular mechanism: thiol adduction and subsequent nerve terminal dysfunction. However, it should be noted that the in vivo neurotoxicity of acrolein and other conjugated , -unsaturated carbonyl and acrylic acid derivatives (e.g., methyl vinyl ketone, methyl acrylate, acrylonitrile) has not been adequately documented. Such research is clearly important and the results could have significant economic and regulatory implications based on the broad industrial applications of Type-2 alkenes (Beauchamp et al., 1985; Witz, 1989) . With respect to risk management, our results could provide a rational basis for predicting the human neurotoxic potential of these and structurally related chemicals. Finally, a growing body of evidence suggests that presynaptic dysfunction in the hippocampus and certain other brain regions is responsible for the early memory loss that characterizes Alzheimer's disease (AD; e.g., see Coleman and Yao, 2003 
